Precision BioSciences, Inc. (DTIL) Social Stream
PRECISION BIOSCIENCES INC (DTIL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PRECISION BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 5 | $26 | $13 | $20 | $0.438 | 4466.21% |
| 2021-11-10 | 5 | $24 | $13 | $19.5 | $0.438 | 4352.05% |
| 2021-11-11 | 5 | $24 | $13 | $18.75 | $0.438 | 4180.82% |
| 2021-12-13 | 4 | $24 | $11 | $18.25 | $0.438 | 4066.67% |
| 2022-03-16 | 5 | $24 | $11 | $18.25 | $0.438 | 4066.67% |
| 2022-03-22 | 5 | $20 | $11 | $16.25 | $0.438 | 3610.05% |
| 2022-05-09 | 4 | $20 | $16 | $18 | $0.438 | 4009.59% |
| 2022-05-23 | 4 | $20 | $16 | $17.666 | $0.438 | 3933.33% |
| 2022-06-09 | 4 | $20 | $16 | $17.666 | $0.438 | 3933.33% |
| 2022-06-17 | 5 | $20 | $7 | $15 | $0.438 | 3324.66% |
| 2022-06-23 | 5 | $20 | $7 | $13.75 | $0.438 | 3039.27% |
| 2022-08-16 | 6 | $20 | $2 | $10 | $0.438 | 2183.11% |
| 2023-03-10 | 5 | $17 | $1 | $7.4 | $0.438 | 1589.5% |
| 2023-03-15 | 5 | $17 | $1 | $7.4 | $0.438 | 1589.5% |
| 2023-06-01 | 5 | $17 | $1 | $6.8 | $0.438 | 1452.51% |
| 2023-07-27 | 6 | $17 | $1 | $5.68 | $0.438 | 1196.8% |
| 2023-07-28 | 6 | $5 | $1 | $3.066 | $0.438 | 600% |
| 2023-10-25 | 6 | $5 | $1 | $2.733 | $0.438 | 523.97% |
| 2023-11-09 | 5 | $5 | $1 | $3 | $0.438 | 584.93% |
The Trend in the Analyst Price Target
Over the past 33 months, DTIL's average price target has gone down $13.86.
Over the past 35 weeks, DTIL's average upside potential has been 733.24%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-10 | 5 | 17 | 1 | 7.400 | 0.910 | 713.19% |
| 2023-08-17 | 6 | 5 | 1 | 2.733 | 0.460 | 494.13% |
| 2023-09-19 | 6 | 5 | 1 | 2.733 | 0.424 | 544.58% |
| 2023-10-25 | 5 | 5 | 1 | 3.000 | 0.286 | 948.95% |
| 2023-11-09 | 5 | 5 | 1 | 3.000 | 0.394 | 661.42% |
DTIL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 17 months, DTIL's average broker recommendation rating worsened by 0.4.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DTIL as an investment opportunity.
- DTIL has a higher upside potential (average analyst target price relative to current price) than 2069.79% of all US stocks.
- DTIL has a lower variance in analysts' estimates than -1523.3% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, PRECISION BIOSCIENCES INC's average analyst price target is greater than 453.29% of them.
- In the context of Healthcare stocks, PRECISION BIOSCIENCES INC's number of analysts covering the stock is higher than 561.51% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PRECISION BIOSCIENCES INC are GNFT, IMTX, and STRO.
View All Top Stocks by Price Target
What is the outlook for DTIL? Use POWR Ratings for clearer insight into price direction.